Yousif Capital Management’s Arcus Biosciences RCUS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$715K Buy
23,202
+154
+0.7% +$3.81K 0.01% 1223
2026
Q1
$498K Sell
23,048
-159
-0.7% -$3.43K 0.01% 1392
2025
Q4
$509K Buy
23,207
+1,674
+8% +$34.2K 0.01% 1406
2025
Q3
$293K Sell
21,533
-3,670
-15% -$38.2K ﹤0.01% 1660
2025
Q2
$205K Buy
25,203
+374
+2% +$3.19K ﹤0.01% 1815
2025
Q1
$195K Buy
24,829
+3,893
+19% +$45.1K ﹤0.01% 1816
2024
Q4
$312K Buy
20,936
+21
+0.1% +$343 ﹤0.01% 1673
2024
Q3
$320K Sell
20,915
-1,239
-6% -$19.5K ﹤0.01% 1699
2024
Q2
$337K Sell
22,154
-2,485
-10% -$40.1K ﹤0.01% 1640
2024
Q1
$465K Sell
24,639
-2,455
-9% -$42.4K 0.01% 1548
2023
Q4
$517K Sell
27,094
-1,605
-6% -$25.7K 0.01% 1513
2023
Q3
$515K Sell
28,699
-1,108
-4% -$22.3K 0.01% 1467
2023
Q2
$605K Sell
29,807
-1,600
-5% -$30.5K 0.01% 1406
2023
Q1
$573K Sell
31,407
-3,955
-11% -$75.6K 0.01% 1419
2022
Q4
$731K Sell
35,362
-8,765
-20% -$241K 0.01% 1328
2022
Q3
$1.15M Buy
44,127
+3,789
+9% +$100K 0.02% 1107
2022
Q2
$1.02M Buy
+40,338
New +$988K 0.01% 1224

Other funds holding RCUS

Yousif Capital Management's RCUS Position: Q2 2026 in Review

Yousif Capital Management increased its Arcus Biosciences (RCUS) stake by 0.67% in Q2 2026, buying an estimated $3.81K and bringing the position to 23,202 shares worth $715K. The position accounts for 0.01% of the portfolio, ranked #1223.

Yousif Capital Management first reported a position in RCUS in Q2 2022 and has held it in 17 quarters since. The position peaked at $1.15M in Q3 2022. 29 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • Yousif Capital Management held 23,202 shares of Arcus Biosciences worth $715K as of Q2 2026.
  • Yousif Capital Management bought 154 Arcus Biosciences shares in Q2 2026, an estimated $3.81K.
  • Arcus Biosciences made up 0.01% of Yousif Capital Management's portfolio in Q2 2026, its #1223 holding.
  • Yousif Capital Management first reported a position in Arcus Biosciences in Q2 2022 and has held it in 17 quarters since.
  • Yousif Capital Management's Arcus Biosciences position peaked at $1.15M in Q3 2022.
  • 29 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on Yousif Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.